-
HIV Therapeutics Market is expected to reach US$ 57.56 Billion by 2033 | DataM Intelligence
02 Feb 2026 11:09 GMT
… infectious diseases worldwide. HIV therapeutics include antiretroviral therapies … .
Market Opportunities
The HIV Therapeutics Market offers substantial … Pfizer Inc.
Theratechnologies Inc.
Abbott Laboratories
Recent Developments:
United States: …
-
HIV Viral Load and Early Infant Treatment Market Insights: Portfolio Priorities, Adoption Trends & Future Demand Outlook
21 Jan 2026 15:23 GMT
… in HIV Viral Load and Early Infant Treatment Market: Roche Diagnostics, Abbott Laboratories … a decade during which global HIV awareness programs, treatment initiatives, and … #47;report/hiv-self-testing-market
HIV-associated Nephropathy Treatment Market …
-
Abbott Laboratories (NYSE:ABT) Q2 2025 Earnings Call Transcript
19 Jul 2025 12:45 GMT
… in the [ Eurosport ] funding for HIV testing. So you — you look … the — with the funding for HIV testing, that’s over $1 … a wonderful day.
Follow Abbott Laboratories (NYSE:ABT) Follow Abbott Laboratories (NYSE:ABT) We …
-
United States Generic Drugs Market Forecast and Company Analysis Report 2025-2033 Featuring Teva Pharma, Aurobindo Pharma, Sun Pharma, Abbott Laboratories, Lupin Pharma, Viatris, Sandoz, Dr. Reddy's - ResearchAndMarkets.com
19 May 2025 16:43 GMT
… Pharmaceuticals
Aurobindo Pharma
Sun Pharmaceuticals
Abbott Laboratories Inc
Lupin Pharmaceuticals, Inc
Viatris … 's Disease
9.9 HIV/AIDS
9.10 Crohn…
-
Transdermal Skin Patches Market Forecast Report and Company Analysis 2025-2033 Featuring Teva, 3M, Nitto Denko, Johnson & Johnson, Luye, Bayer, Novartis, Beiersdorf, Viatris, Abbott Laboratories - ResearchAndMarkets.com
04 Apr 2025 08:04 GMT
… to 2033.
Human immunodeficiency virus (HIV), osteoporosis, migraine, Parkinson's … AG
Beiersdorf AG
Viatris Inc.,
Abbott Laboratories
Key Attributes:
Report Attribute
Details …
-
Biotechnology Market Leading Key Players: Sanofi, Biogen, Abbott Laboratories and Pfizer, Inc.
22 Jan 2025 11:36 GMT
… hepatitis, viral infections, and HIV. Biogen Inc. targets neurological … . Other major contributors are Abbott Laboratories and Pfizer, Inc., which … Bristol-Myers Squibb
• Sanofi
• Biogen
• Abbott Laboratories
• Pfizer Inc.
• Amgen Inc.
• Novo …
-
Hundreds of lawsuits allege Abbott Laboratories’ formula for premature infants made babies sick. But is the formula to blame?
03 Nov 2024 11:23 GMT
… preterm infants — north suburban-based Abbott Laboratories and Indiana-based Mead Johnson … companies, totaling $495 million against Abbott Laboratories and $60 million against Mead … federal Medicaid program, like hearing aids for most adults, that states …
-
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
16 Oct 2024 20:37 GMT
… .
Image source: The Motley Fool.
Abbott Laboratories (ABT 1.52%)
Q3 2024 … think it was during the HIV pandemic. So I think the …
-
Abbott slumps over 8% after missing Q4 revenue targets, lower Q1 forecast
22 Jan 2026 17:40 GMT
Abbott Laboratories stock slumped on Thursday following … 11:36 a.m. EST, Abbott Laboratories shares were valued at $110 … to diagnostics like Cologuard, which aids in detecting colorectal cancer — the …
-
Biosensors Market Forecast 2025-2033: Total Revenues to Exceed $75.84 Billion by 2033 | Astute Analytica
22 Jan 2026 18:26 GMT
… $ 120 million funding for handheld HIV testers, further amplify this impact …
Nova Biomedical
LifeScan, Inc.
Medtronic
Abbott Laboratories
Roche
DirectSens GmbH
Zimmer …
About
© 1995-2026